Allergan (NYSE:AGN) has coverage initiated with a Hold rating and $144.95 price target

Analyst Ratings For Allergan (NYSE:AGN)

Story continues below

Today, Jefferies Financial Group initiated coverage on Allergan (NYSE:AGN) with a Hold with a price target of $144.95.

There are 14 Buy Ratings, 8 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Allergan (NYSE:AGN) is Buy with a consensus target price of $188.7342 per share, a potential 31.18% upside.

Some recent analyst ratings include

  • 4/15/2019-Allergan (NYSE:AGN) has coverage initiated with a Hold rating and $144.95 price target
  • 3/19/2019-Allergan (NYSE:AGN) has coverage initiated with a Buy ➝ Buy rating and $178.00 price target
  • On 3/7/2019 Brent L Saunders, Chairman, bought 1,760 with an average share price of $143.67 per share and the total transaction amounting to $252,859.20.
  • On 11/16/2018 Matthew M. Walsh, CFO, bought 1,000 with an average share price of $157.00 per share and the total transaction amounting to $157,000.00.
  • On 9/6/2018 Christopher J. Coughlin, Director, bought 10,000 with an average share price of $190.64 per share and the total transaction amounting to $1,906,400.00.
  • On 8/30/2018 Joseph H. Boccuzi, Director, bought 900 with an average share price of $190.59 per share and the total transaction amounting to $171,531.00.
  • On 5/17/2018 William Meury, EVP, sold 24,425 with an average share price of $154.59 per share and the total transaction amounting to $3,775,860.75.
  • On 3/15/2018 Maria Teresa Hilado, Insider, bought 895 with an average share price of $167.39 per share and the total transaction amounting to $149,814.05.
  • On 3/8/2018 Brent L. Saunders, CEO, bought 3,300 with an average share price of $152.53 per share and the total transaction amounting to $503,349.00.

Recent Trading Activity for Allergan (NYSE:AGN)
Shares of Allergan closed the previous trading session at 144,01 −0,94 0,65 % with 142.71 shares trading hands.

An ad to help with our costs